KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$14.47 USD
-0.92 (-5.98%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $14.49 +0.02 (0.14%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Earnings News For KALV
-
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
-
KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year
-
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
-
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
-
KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update
-
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
-
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
-
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
-
Analysts Estimate KalVista Pharmaceuticals, Inc. (KALV) to Report a Decline in Earnings: What to Look Out for
-
KalVista Pharmaceuticals, Inc. (KALV) Reports Q3 Loss, Misses Revenue Estimates
-
KalVista Pharmaceuticals, Inc. (KALV) Expected to Beat Earnings Estimates: Should You Buy?
-
KalVista Pharmaceuticals (KALV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
KalVista Pharmaceuticals (KALV) Q1 Earnings Preview: What to Look Out For